Artelo biosciences, inc. (ARTL)
Income statement / Quarterly
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Nov'14May'14Feb'14
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

Operating Expenses Abstract
General and administrative

440

403

286

402

57

205

236

104

30

136

87

19

3

0

0

0

0

0

-

-

-

-

3

0

Professional fees

215

266

433

354

209

167

121

236

119

107

28

76

8

9

4

5

5

14

4

2

6

2

4

6

Research and Development Expense

714

666

233

184

489

184

332

236

647

33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating Expenses

1,370

1,336

953

941

757

556

690

577

798

277

115

95

11

9

4

5

5

15

4

2

6

2

8

6

Operating Income (Loss)

-1,370

-1,336

-953

-941

-757

-556

-690

-577

-798

-277

-115

-95

-11

-9

-4

-5

-5

-15

-4

-2

-6

-2

-8

-6

Other Expense, Nonoperating [Abstract]
Total other expense

0

0

-

32

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Represents the change in fair value for the period of warrant derivative liability.

0

29

-

563

333

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

0

30

-

596

333

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

0

1

-

-

-

-

-

-

-

-

-

-

-

Total other income

-

-

-

-

-

-

-

-

-

-

-

-0

-1

-

-

-

-

-

-

-

-

-

-

-

Income Tax Expense (Benefit)

-

-

-

0

-

-

-

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Net Income (Loss) Attributable to Parent

-1,370

-1,306

-845

-344

-424

-556

-690

-577

-798

-277

-115

-96

-13

-9

-4

-5

-5

-15

-4

-2

-6

-2

-8

-6

Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax

9

16

0

0

-3

4

-0

-10

-1

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation adjustments

9

16

0

0

-3

4

-0

-10

-1

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total comprehensive loss

-1,360

-1,290

-845

-344

-428

-552

-690

-587

-799

-278

-

-96

-13

-

-

-

-

-

-

-

-

-

-

-

Earnings Per Share, Basic

-0.40

-0.39

-0.29

-0.17

-0.22

-0.32

-

-0.36

-0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings Per Share, Diluted

-0.40

-0.40

-0.34

-0.40

-0.40

-0.32

-

-0.36

-0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Number of Shares Outstanding, Basic

3,425

3,361

2,958

2,058

1,917

1,754

-

1,592

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Number of Shares Outstanding, Diluted

3,425

3,379

2,749

2,267

1,917

1,754

-

1,592

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and Diluted Loss per Common Share (in dollars per share)

-

-

-

-

-

-

-

-

-

-0.02

-0.02

-0.01

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

-0.07

Basic and Diluted Weighted Average Common Shares Outstanding (in shares)

-

-

-

-

-

-

-

-

11,677

11,345

10,840

8,809

7,640

7,640

7,640

7,640

7,640

7,640

7,311

6,314

6,000

6,000

6,000

99